Post-Transplant Complement-Binding Donor-Specific Anti-HLA Antibodies Are Strong Predictors of Kidney Allograft Outcome

被引：0
|
作者：
Lefaucheur, C. [1 ]
Loupy, A. [2 ]
Suberbielle, C. [3 ]
Charron, D. [3 ]
Legendre, C. [2 ]
Glotz, D. [1 ]
Zeevi, A. [4 ]
机构：
[1] St Louis Hosp, Nephrol & Kidney Transplantat, Paris, France
[2] Hop Necker Enfants Malad, Nephrol & Kidney Transplantat, Paris, France
[3] St Louis Hosp, Histocompatibil, Paris, France
[4] Univ Pittsburgh, Pittsburgh, PA USA
来源：
TRANSPLANTATION | 2012年 / 94卷 / 10期
关键词：
D O I：
10.1097/00007890-201211271-00118
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
900
引用
收藏
页码：64 / 64
页数：1
相关论文
共 50 条
  • [41] Role of C1q-binding donor-specific anti-HLA antibodies in Premature and Accelerated Kidney Allograft Interstitial Fibrosis
    Louis, Kevin
    Viglietti, Denis
    Aubert, Olivier
    Loupy, Alexandre
    Lefaucheur, Carmen
    TRANSPLANTATION, 2018, 102 : S276 - S276
  • [42] ROLE OF C1Q-BINDING DONOR-SPECIFIC ANTI-HLA ANTIBODIES IN PREMATURE AND ACCELERATED KIDNEY ALLOGRAFT INTERSTITIAL FIBROSIS
    Viglietti, D.
    Louis, K.
    Aubert, O.
    Glotz, D.
    Legendre, C.
    Loupy, A.
    Lefaucheur, C.
    TRANSPLANT INTERNATIONAL, 2019, 32 : 5 - 5
  • [43] Non-Complement-Binding Anti-HLA Antibodies and Kidney-Allograft Survival
    Couzi, L.
    Guerville, F.
    Lepreux, S.
    Merville, P.
    Taupin, J.
    Guidicelli, G.
    TRANSPLANTATION, 2014, 98 : 82 - 82
  • [44] DONOR SPECIFIC ANTI-HLA ANTIBODIES IN TRANSPLANT GLOMERULOPATHY
    Eng, Hooi Sian
    Bennett, Greg
    Tsiopelas, Eleni
    Chang, Sean
    Bardy, Peter
    Russ, Graeme
    Coates, P. Toby H.
    HUMAN IMMUNOLOGY, 2008, 69 : S109 - S109
  • [45] Post-transplant SCD30 levels, anti-HLA class II antibodies and renal allograft outcome
    Grenzi, Patricia
    Campos, Erika F.
    Tedesco-Silva, Helio
    Franco, Marcello
    Medina-Pestana, Jose O.
    Gerbase-DeLima, Maria
    TISSUE ANTIGENS, 2010, 75 (05): : 597 - 598
  • [46] Post-transplant anti-HLA class I and class II antibodies as risk factor for kidney allograft failure
    Li, Xiaobei
    Yin, Hang
    Wang, Wei
    Hu, Xiaopeng
    Zhang, Yong
    Ma, Linlin
    Wang, Yong
    Zhang, Xiaodong
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 444 - 444
  • [47] The Fate of Pre-Transplant Donor-Specific Anti-HLA Antibodies after Transplantation
    Marfo, K.
    Ling, M.
    Greenstein, S.
    Chapochnick-Friedmann, J.
    Glicklich, D.
    Kayler, L.
    de Boccardo, G.
    Kinkhabwala, M.
    Akalin, E.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 234 - 234
  • [48] Circulating Donor-Specific Anti-HLA Antibodies Associate With Immune Activation Independent of Kidney Transplant Histopathological Findings
    Van Loon, Elisabet
    Lamarthee, Baptiste
    Barba, Thomas
    Claes, Sandra
    Coemans, Maarten
    de Loor, Henriette
    Emonds, Marie-Paule
    Koshy, Priyanka
    Kuypers, Dirk
    Proost, Paul
    Senev, Aleksandar
    Sprangers, Ben
    Tinel, Claire
    Thaunat, Olivier
    Van Craenenbroeck, Amaryllis H.
    Schols, Dominique
    Naesens, Maarten
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [49] Characteristics of donor-specific anti-HLA antibodies and outcome in renal transplant patients treated with a standardized induction regimen
    Zecher, Daniel
    Bach, Christian
    Staudner, Christoph
    Boeger, Carsten A.
    Bergler, Tobias
    Banas, Bernhard
    Spriewald, Bernd M.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 (04) : 730 - 737
  • [50] Pretransplant Donor-specific anti-HLA Antibodies as Predictors of Early Allograft Rejection in ABO-Compatible Liver Transplantation
    Musat, Alexandru I.
    Pigott, Courtney M.
    Ellis, Thomas M.
    Agni, Rashmi M.
    Leverson, Glen E.
    Powell, Amy J.
    Richards, Katelyn R.
    D'Alessandro, Anthony M.
    Lucey, Michael R.
    LIVER TRANSPLANTATION, 2013, 19 (10) : 1132 - 1141
12345